BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
43 hedge funds and large institutions have $17.7M invested in BRAINSTORM CELL THERAPUTC in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
43
Holding in Top 10
–
Calls
$2.96M
Puts
$3.87M
Top Buyers
| 1 | +$416K | |
| 2 | +$148K | |
| 3 | +$112K | |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$40K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$21.4K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$568K | |
| 3 | -$405K | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$353K |
| 5 |
HF
HRT Financial
New York
|
-$268K |